RZLT - Rezolute secures innovation passport designation from U.K. for RZ358 treating hypoglycemia January, 23 2024 09:39 AM Rezolute Inc. 2024-01-23 09:39:10 ET More on Rezolute Rezolute: Negative EV Opportunity Initiating A Phase 3 Ultra-Orphan Pediatric Study Seeking Alpha’s Quant Rating on Rezolute Historical earnings data for Rezolute Financial information for Rezolute For further details see: Rezolute secures innovation passport designation from U.K. for RZ358 treating hypoglycemia